Article 04 Mar 2026 The Trap Of Obviousness-Type Double Patenting When The Reference Case Has Different Ownership United States IP
Article 01 May 2024 Federal Circuit Affirms Obviousness Of Rifaximin Polymorph Patents And Denial Of Motion To Modify Judgment After Post-Trial Patented Indication Carve Out United States IP
Article 25 Oct 2021 EXCLUSIVE RIGHTS: Intellectual Property — Don't Get Caught Double Patenting! (Podcast) United States IP
Article 11 Oct 2017 Canada Institutes Certificates Of Supplementary Protection For Approved Drug Products United States IP